-

As Amoxicillin Shortage Continues, USAntibiotics Urges Lawmakers to Consider Policies and Partnerships That Support U.S. Drug Manufacturers

BRISTOL, Tenn.--(BUSINESS WIRE)--USAntibiotics, the sole licensed American manufacturer of penicillin-based Amoxicillin and Amoxicillin Clavulanate, the popular antibiotics commonly known as Amoxil® and Augmentin®, released the following statement ahead of the U.S. House Energy and Commerce Committee Subcommittee on Oversight and Investigations hearing titled “Examining The Root Causes Of Drug Shortages: Challenges In Pharmaceutical Drug Supply Chains.”

“Today’s hearing is an opportunity to identify solutions to address not only current drug shortages, but to prevent these shortages from happening in the future. We have witnessed time and again that the root cause of pharmaceutical drug shortages is the lack of domestic manufacturing in the United States,” said Patrick Cashman, president of USAntibiotics. “As the only remaining American manufacturer of Amoxicillin finished doses, we urge Congress to focus on long-term solutions to protect Americans’ national and public health security.”

“We believe American medicine should be made in America. It is a public health risk and a national crisis that so much of our medicine and pharmaceutical manufacturing for the United States has been offshored to foreign countries, like China, leaving us vulnerable to their whims and resulting in a lack of transparency and weakened supply chain. For America to build and maintain a sustainable generic drug industry, lawmakers must support policies that prioritize U.S. manufacturers, and ensure public-private partnerships with relevant agencies to give preference to domestically produced drugs,” added Cashman.

About USAntibiotics

USAntibiotics is the only U.S. manufacturer of Amoxicillin and Amoxicillin Clavulanate, commonly known as Amoxil and Augmentin. Based in Bristol, Tenn., it operates a world-class, 360,000-square-foot antibiotic production facility with the sole focus of making quality, life-saving antibiotics widely available for the benefit of all Americans. USAntibiotics is part of the Jackson Healthcare family of companies. For more information, visit www.us-antibiotics.com.

Contacts

For More Information, Contact:
media@us-antibiotics.com

USAntibiotics


Release Versions

Contacts

For More Information, Contact:
media@us-antibiotics.com

More News From USAntibiotics

USAntibiotics Awarded FDA National Priority Voucher for Domestic Manufacturing of Critical Antibiotic

BRISTOL, Tenn.--(BUSINESS WIRE)--USAntibiotics, the country’s only domestic manufacturer of amoxicillin (Amoxil®) and amoxicillin clavulanate (Augmentin®), announced today that the U.S. Food and Drug Administration (FDA) selected its Augmentin XR product for the agency's inaugural Commissioner's National Priority Voucher (CNPV) Program. The new voucher promises a review decision within one to two months following submission of a complete application, collapsing the typical 10 to 12-month FDA ti...

USAntibiotics Working with Walmart and McKesson to Support U.S. Manufacturing of Amoxicillin

BRISTOL, Tenn.--(BUSINESS WIRE)--USAntibiotics, the nation’s lone remaining manufacturer of amoxicillin and amoxicillin clavulanate, today announced a new collaboration with Walmart and McKesson through their joint venture partner ClarusONE Sourcing Services to provide domestically manufactured antibiotics made by USAntibiotics in the United States for millions of patients nationwide. The collaboration will see USAntibiotics supply millions of life-saving doses of amoxicillin directly to Walmar...

USAntibiotics Names Mark Tengler Senior Vice President of Manufacturing Technologies

BRISTOL, Tenn.--(BUSINESS WIRE)--USAntibiotics, the only U.S. manufacturer of penicillin-based Amoxicillin and Amoxil Clavulanate, the life-saving antibiotics commonly known as Amoxil® and Augmentin®, today announced the appointment of Mark Tengler to the position of senior vice president of manufacturing technologies. A seasoned pharmaceutical leader with more than three decades of expertise, Tengler will oversee all aspects of manufacturing at the company’s world-class 394,000-square-foot fac...
Back to Newsroom